March 2009/1

NextPharma Technologies Expands Temperature Controlled Storage Facilities in Stockerau, Austria

Surrey, UK, 12th March 2009

NextPharma Technologies, a leading provider of pharmaceutical product development, contract manufacturing, cold chain and distribution outsourcing services, is pleased to announce the expansion of its Cold Chain and Logistics (CLS) business in Austria.

The warehouse expansion will create a facility with a 2,000 square metre area,  3,500 additional pallet spaces and  temperature controlled storage at 15 - 25 degrees °C.  The ground breaking ceremony to mark the commencement of this expansion work  took place on 6th March and the fully completed new facility is scheduled to be operational by September 2009.

In addition to the above expansion NextPharma has also increased its temperature controlled cold storage facilities by adding additional cold chain storage capacity to its existing warehouse to provide 280 cold storage pallet places at 2 - 8 °C.  Control testing of the new area has now been completed and the facility opened for business in February 2009.

Jost Bunse, Managing Director of Cold Chain and Logistics Services explained ‘there has been rapid growth in demand for our services as more and more products require storage at colder temperatures. We want to build on the success of our United States cold chain capabilities in Europe and this expansion is an important step in that direction’.

NextPharma develops, manufactures, packages, and distributes a broad range of products and formulations for its customers including solids, liquids and semi-solid dosage forms, antibiotics, hormones and controlled release medicines. It has an established leadership position in the high technology area of injectables manufacturing (lyophilized and liquid fill), with particular expertise in product development and manufacture of oncology medicines.
 

Contact:

Bill Wedlake        
Chief Executive Officer  
NextPharma Technologies Holding Limited
Tel +44 (0) 1483 479 121

Notes to Editors:

About NextPharma

NextPharma Technologies, headquartered in the UK and founded in 2000, is a world class outsourcing partner to the pharmaceutical and biotechnology industry.  We offer a full range of services from early phase product development, through clinical trial packaging to high volume commercial manufacturing. We are a world leader in lyophilization, sterile fill finish and pellet technologies and in specialist product manufacturing including cytotoxics, hormones, penicillins, cephalosporins and narcotics. Our sterile development and production offers a full range of drug delivery technologies including pre-filled syringes, vials and ampoules.   

We operate globally with seven product development centres, seven manufacturing plants and six temperature controlled storage and distribution sites across Europe and North America, supplying customers in North America, Europe and Japan.    

We have 1,200 employees dedicated to serving over 200 customers world wide and a customer base, which includes many of the world’s leading pharmaceutical, specialty pharma and biotech companies. 

We have a proven track record in almost all pharmaceutical technologies and product forms and in addition to the specialist areas above have capabilities in solids, semi- solids, liquids, sprays and dry dosage form technologies.    

All of our sites are either FDA inspected, in the process of upgrade for inspection or targeted for upgrade for inspection.